168 related articles for article (PubMed ID: 17701712)
1. Macrolide resistance in the normal microbiota after Helicobacter pylori treatment.
Jakobsson H; Wreiber K; Fall K; Fjelstad B; Nyrén O; Engstrand L
Scand J Infect Dis; 2007; 39(9):757-63. PubMed ID: 17701712
[TBL] [Abstract][Full Text] [Related]
2. [Double blind randomized multicentre study of a seven-day eradication regime of Helicobacter pylori by omeprazole, clarithromycin and ornidazole vs. omeprazole, clarithromycin and metronidazole].
Díte P; Kunovská M; Pulgretová D; Woznica V; Petrtýl J; Hůlek P; Pásková J; Dostalík Z; Novotný I; Procházka V; Hegyi P; Zelenková J; Samek M; Králová Z; Vyhnálek P; Matejovic F; Weinberg J; Kyzeková J
Vnitr Lek; 2002 Oct; 48(10):976-80. PubMed ID: 16737149
[TBL] [Abstract][Full Text] [Related]
3. [Influence of resistance of Helicobacter pylori to antibiotics on the Helicobacter pylori eradication regimens].
Cheng H; Hu FL; Li J
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(38):2679-82. PubMed ID: 17199976
[TBL] [Abstract][Full Text] [Related]
4. Clarithromycin treatment selects for persistent macrolide-resistant bacteria in throat commensal flora.
Jönsson M; Qvarnström Y; Engstrand L; Swedberg G
Int J Antimicrob Agents; 2005 Jan; 25(1):68-74. PubMed ID: 15620829
[TBL] [Abstract][Full Text] [Related]
5. [The cause of failure of eradication treatment of Helicobacter pylori].
Chen G; Takeuchi Y; Kikuchi R; Arai D; Fukuchi K; Gomi K
Rinsho Byori; 2005 Aug; 53(8):692-7. PubMed ID: 16190353
[TBL] [Abstract][Full Text] [Related]
6. Effects of primary metronidazole and clarithromycin resistance to Helicobacter pylori on omeprazole, metronidazole, and clarithromycin triple-therapy regimen in a region with high rates of metronidazole resistance.
Wong WM; Gu Q; Wang WH; Fung FM; Berg DE; Lai KC; Xia HH; Hu WH; Chan CK; Chan AO; Yuen MF; Hui CK; Lam SK; Wong BC
Clin Infect Dis; 2003 Oct; 37(7):882-9. PubMed ID: 13130398
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole triple-therapy regimens.
Filipec Kanizaj T; Katicic M; Skurla B; Ticak M; Plecko V; Kalenic S
Helicobacter; 2009 Feb; 14(1):29-35. PubMed ID: 19191893
[TBL] [Abstract][Full Text] [Related]
8. A randomized clinical trial to determine the efficacy of regimens containing clarithromycin, metronidazole, and amoxicillin among histologic subgroups for Helicobacter pylori eradication in a developing country.
Fischbach LA; Bravo LE; Zarama GR; Bravo JC; Ojha RP; Priest EL; Collazos T; Casabon AL; Guerrero LZ; Singh KP; Correa P
Helicobacter; 2009 Apr; 14(2):100-8. PubMed ID: 19298337
[TBL] [Abstract][Full Text] [Related]
9. Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan.
Hu CT; Wu CC; Lin CY; Cheng CC; Su SC; Tseng YH; Lin NT
J Gastroenterol Hepatol; 2007 May; 22(5):720-3. PubMed ID: 17444862
[TBL] [Abstract][Full Text] [Related]
10. [The epidemiology of Helicobacter pylori resistance to antibiotics in Beijing].
Cheng H; Hu FL
Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2754-7. PubMed ID: 16324315
[TBL] [Abstract][Full Text] [Related]
11. Pylera for the eradication of Helicobacter pylori infection.
Saleem A; Qasim A; O'Connor HJ; O'Morain CA
Expert Rev Anti Infect Ther; 2009 Sep; 7(7):793-9. PubMed ID: 19735221
[TBL] [Abstract][Full Text] [Related]
12. Microbial ecology and treatment of Helicobacter pylori infections: review.
Adamsson I; Edlund C; Nord CE
J Chemother; 2000 Feb; 12(1):5-16. PubMed ID: 10768510
[TBL] [Abstract][Full Text] [Related]
13. [Resistance to antibiotics used in Helicobacter pylori infection in children].
Maciorkowska E; Kaczmarski M; Kowalczuk J; Kondej-Muszyńska K; Roszko I; Cieśla J; Zielińska A; Musaibili S
Pol Merkur Lekarski; 2004 Jun; 16(96):543-6. PubMed ID: 15510893
[TBL] [Abstract][Full Text] [Related]
14. Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates.
Romano M; Iovene MR; Russo MI; Rocco A; Salerno R; Cozzolino D; Pilloni AP; Tufano MA; Vaira D; Nardone G
J Clin Pathol; 2008 Oct; 61(10):1112-5. PubMed ID: 18755715
[TBL] [Abstract][Full Text] [Related]
15. [Sequential therapy regimen for Helicobacter pylori infection in children].
Kalach N; Serhal L; Bergeret M; Spyckerelle C; Dupont C; Raymond J
Arch Pediatr; 2008 Feb; 15(2):200-1. PubMed ID: 18249101
[No Abstract] [Full Text] [Related]
16. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
[TBL] [Abstract][Full Text] [Related]
17. Alaska sentinel surveillance for antimicrobial resistance in Helicobacter pylori isolates from Alaska native persons, 1999-2003.
Bruce MG; Bruden DL; McMahon BJ; Hennessy TW; Reasonover A; Morris J; Hurlburt DA; Peters H; Sacco F; Martinez P; Swenson M; Berg DE; Parks D; Parkinson AJ
Helicobacter; 2006 Dec; 11(6):581-8. PubMed ID: 17083381
[TBL] [Abstract][Full Text] [Related]
18. [Susceptibility of 36 Helicobacter pylori clinical isolates to four first-line antibiotics and virulence factors].
Díaz-Reganon J; Alarcón T; Domingo D; López-Brea M
Rev Esp Quimioter; 2006 Mar; 19(1):34-8. PubMed ID: 16688289
[TBL] [Abstract][Full Text] [Related]
19. Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea.
Kim JM; Kim JS; Jung HC; Kim N; Kim YJ; Song IS
Antimicrob Agents Chemother; 2004 Dec; 48(12):4843-7. PubMed ID: 15561865
[TBL] [Abstract][Full Text] [Related]
20. High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children.
Agudo S; Alarcón T; Cibrelus L; Urruzuno P; Martínez MJ; López-Brea M
Rev Esp Quimioter; 2009 Jun; 22(2):88-92. PubMed ID: 19544100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
